Alexandria Real Estate Equities Inc (ARE)

Investment Committee Summary

Investment Thesis

At $54.04 (25 August 2026) Alexandria trades on 26 times forward earnings, deep in the lower half of its 52-week range and on a dividend yield high enough to read as a distress signal rather than a comfort. That price implies the market doubts lab-space demand has found a floor. The engine is more balanced than the tape. Probability-weighting the scenario tree gives $54.97, the twelve-month target is $54.86, and the triangulated fair value is $53.23; the shares are fairly valued against that anchor set, a gap of -1%, and the simulation is close to a coin toss on whether fair value clears the market price. Margin assumptions rather than growth carry most of the outcome dispersion, and an operating margin of 13% shows how much the impairment cycle has already taken. HOLD follows directly: carrying net debt of ~$12.5B against purpose-built assets prices genuine distress risk, yet the shares have already fallen a long way from the 52-week high, which weakens the case for outright sale at this level. The most damaging risk is structural rather than cyclical — purpose-built laboratory space losing tenancy to industry consolidation and cheaper competing supply.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($54.04) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The steelman bear is structural, not cyclical. The lab-construction boom left the key clusters with years of excess supply just as biotech funding normalised and large pharma cut research footprints; AI-led discovery may permanently reduce the wet-lab space required per research dollar, which would make the oversupply an obsolescence problem rather than a timing problem. The accounts already show the damage: a net loss driven by impairments, with development capital still running above depreciation into a market that does not need the space. If vacancy keeps rising, renewal rents turn negative and the pipeline delivers into absent demand, then cash flow declines compound with cap-rate expansion on net debt of ~$12.5B. Purpose-built laboratory improvements have little alternative use, so the recovery value is closer to the land than to the building. Earnings and the multiple compress together, and the equity re-prices toward the structural case — below the 52-week low.

Key Debate

Gross Margin explains 54% of Monte Carlo outcome variance — the single variable that decides which side is right.

What the Market Is Pricing In

At the current price, the market pays 32.0× consensus forward EPS, and a peer median 37.2×.

Variant perception: the house view is above-consensus, and the thesis is primarily growth-driven.

Scenario Analysis

The scenario tree spans a structural 'Structural — Obsolescence / Demand Loss (Office/Hotel)' downside ($24.50) to a 'Bull — Re-Rate' bull case ($97.10); the probability-weighted blend (PWEV $54.97) is +2% versus spot.

Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 1.4% of revenue; free cash flow net of SBC is $-0.50B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.

Scenario rationale — the driver path behind every target:

• Structural — Obsolescence / Demand Loss (Office/Hotel) (20%, $24.50). Structural impairment — demand loss / obsolescence — assets re-price below the expiring rate: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
• Cyclical Occupancy / RevPAR Decline (17%, $41.10). Cyclical downturn — utilisation + realised rate on re-pricing + cap rates / interest rates weakens for 1–2 years before normalising.
• Base — Stabilization + FFO (35%, $57.00). Mid-cycle — normalised utilisation + realised rate on re-pricing + cap rates / interest rates; disciplined capital allocation; steady returns.
• Growth — Recovery / Conversion / Pricing (20%, $76.80). Upside — recovery + repricing lifts earnings above mid-cycle; the multiple expands modestly.
• Bull — Re-Rate (8%, $97.10). Upside tail — sustained tight conditions or a structural re-rate on recovery + repricing.

Valuation Triangulation

Two weighted anchors — a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat two numbers as two independent votes.

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name DCF, sum-of-parts, peer P/E re-rate are not computed, so 60% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

FFO, P/FFO & Distributions

For a REIT, GAAP EPS is meaningless — depreciation is a massive non-cash charge, so REITs are valued on Funds From Operations (FFO ≈ net income + real-estate D&A) and P/FFO, not P/E. Every 'earnings' and 'multiple' figure in this report is therefore on an FFO basis.

The valuation runs on FFO × P/FFO (the standard REIT frame); the cash-flow DCF is omitted (a REIT's development/maintenance capex is funded against the asset base, not free cash). The dividend yield (8.0%) is the income anchor; cap-rate / interest-rate moves and same-store NOI drive the scenarios.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $50.34 and 46% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (54% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $83.88; the peer-median forward P/E is 37.2x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.

Across all anchors the spread is 61% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Peer Quality & Weighting

Quality-weighted forward P/E: 32.6× (simple median 37.2×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $39.41–$84.26, centre $57.60 (+7% vs spot); spot sits at the 33rd percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Bull — Re-Rate): $97.10.

Company Overview & Business Model

Alexandria Real Estate Equities Inc — REAL ESTATE · REIT - OFFICE. Alexandria Real Estate Equities, Inc. is an American real estate investment trust that invests in office buildings and laboratories leased to tenants in the life science and technology industries.

How it makes money.

Edge. Narrow moat. Authored moat rationale withheld pending re-authoring.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 1% of revenue.

Competitive Moat

Moat sources:

• irreplaceable cluster locations adjacent to top research universities/NIH ecosystems
• purpose-built lab infrastructure with high tenant switching cost mid-program
• long-duration leases to credit biopharma/institutional tenants
• NO protection against new lab supply: the 2021-23 development wave is the direct threat

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.16 vs analyst floor +0.00 → delta +0.16 (n=43 mgmt / 21 Q&A; 6th pctile across the S&P book, z -1.5).

Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).

News (last 365d, 1240 articles): avg ticker sentiment -0.08 (bullish 10% / bearish 26%)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

• 2026-10-31 (~68d) — Development pipeline delivery / lease-up milestones on 2024-2026 starts (authored)
• 2026-12-15 (~113d) — Non-core asset dispositions / JV recycling to fund the pipeline without equity issuance (authored)
• 2027-02-15 (~175d) — Guidance reset on same-property NOI and occupancy trough (authored)

Forecast Track Record

• EPS surprise: beat 38% of the last 8 quarters; average surprise -106.4%.
• Prior-forecast backtest (12 snapshots, 2026-06-27→2026-08-20): directional hit-rate 100%; mean predicted +8.4% vs realised +6.8%. Disconfirming track record is reported, not suppressed.

Catalyst Timeline

5 catalysts in the next 90 days (of 15 tracked). Importance 1–3; confidence 0–1.

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 5 evaluable (1 lacked data).

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Occupancy of operating properties (North America) < 90.5% (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Same-property cash NOI growth (year-on-year) < 0% (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Cash rental-rate change on lease renewals and re-leasing < 0% (2 consecutive prints). Negative cash re-leasing spreads mean the standing book reprices downward as leases roll, converting lab-space oversupply into a durable FFO decline rather than a pause.
• FY FFO per share guidance < $1.95 (single event). (rationale withheld pending re-authoring — frozen figure or verdict)
• Quarterly real-estate impairment charges > $500M in a single quarter (single event). (rationale withheld pending re-authoring — frozen figure or verdict)

Fact / Inference / Speculation

• FACT: Spot $54.04; 52-week range $39.41–$84.26; engine rating HOLD; house target $54.86 (+2%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
• INFERENCE: Triangulated FV $53.23 (-1% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

42.7/100 (confidence band 27.8–57.6), 4th percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.

Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.

Score history: 38.6 → 38.6 → 39.2 → 39.2 → 39.2 → 42.6 → 42.3 → 42.3.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $54.97.

Factor Exposures

Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Market interaction: correlation vs SPY +0.36, vs QQQ +0.24 (trailing ~1y daily returns).

Options Intelligence

Preferred structure: Covered Call. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.

• range-bound with fair premium — harvest income against a holding
• Direction neutral from the overlay conviction/rating (read-only input).
• IV/RV at the 48th percentile of the cross-section → mid vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
• Reported alongside and not used to select: this name's own ATM IV sits at the 67th percentile of its own month-end history (decile 7). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
• IV term structure is in contango (longer-dated richer, slope +6.8pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.

IV term structure (contango, slope +6.8pp): 25-DTE 37% · 53-DTE 42% · 235-DTE 43%

Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.

Alternatives: Cash-Secured Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Position Sizing Framework

Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Options Overlay

A defined-risk way to express the HOLD equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.

Market signals — ATM IV 36.6% (subdued regime) · expected move ±7.9% (2026-09-18) · put/call OI 0.97 · ATM Δ 0.46 / Θ -0.04 / ν 0.06. Direction: NEUTRAL (implied return -1.5% to triangulated fair value $53.23).

Covered Call (if held) (Income / neutral) — Short 57.5 C · 2026-09-18 · premium $0.88 · yield 1.6% · priced from the listed chain (EOD marks)

Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Illustrative — no outcome is implied or guaranteed.

Put Spread (income) (Income / would-own) — Short 50 P / Long 45 P · 2026-10-16 · net $1.15 · net entry $48.85 · yield 2.3% · RoR 30.0% · max loss $3.85 · priced from the listed chain (EOD marks)

Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.

Protective Collar (if held) (Hedge) — Long 47.5 P / Short 60 C · 2027-01-15 · net $-0.23 · floor -12.0% · cap +11.0% · priced from the listed chain (EOD marks)

For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.

Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies +2% vs spot
• Monte Carlo median implies -7% vs spot
• Bear case (Structural — Obsolescence / Demand Loss (Office/Hotel)) downside is -55% vs spot
• Net: the valuation anchor itself sits 1.5% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Assumption Register

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Research Provenance

Load-Bearing Assumptions

No DCF anchor is meaningful for this asset; the blend leans 62% on probability-weighted scenarios and 37% on the Monte Carlo median — the scenario probabilities are the load-bearing inputs.